Huron Consulting Group (NASDAQ:HURN) Updates FY 2026 Earnings Guidance

Huron Consulting Group (NASDAQ:HURN) updated its FY 2026 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of 9.000-9.400 for the period, compared to the consensus estimate of 8.810. The company issued revenue guidance of $1.9 billion-$1.9 billion, compared to the consensus revenue estimate of $1.8 billion.

Huron Consulting Group Price Performance

Shares of NASDAQ HURN traded up $4.86 during midday trading on Tuesday, reaching $121.37. 284,772 shares of the company traded hands, compared to its average volume of 284,643. The stock’s 50-day simple moving average is $104.99 and its 200-day simple moving average is $127.91. The company has a debt-to-equity ratio of 2.10, a quick ratio of 2.22 and a current ratio of 2.22. Huron Consulting Group has a 12 month low of $84.88 and a 12 month high of $186.77. The firm has a market cap of $1.97 billion, a PE ratio of 20.71 and a beta of 0.12.

Huron Consulting Group (NASDAQ:HURN) last released its quarterly earnings results on Tuesday, May 5th. The business services provider reported $1.73 EPS for the quarter, topping analysts’ consensus estimates of $1.58 by $0.15. Huron Consulting Group had a return on equity of 29.41% and a net margin of 5.94%.The business had revenue of $451.77 million for the quarter, compared to analyst estimates of $437.12 million. During the same period in the prior year, the company earned $1.68 EPS. Huron Consulting Group’s revenue for the quarter was up 12.1% on a year-over-year basis. Huron Consulting Group has set its FY 2026 guidance at 8.350-9.150 EPS. As a group, equities analysts anticipate that Huron Consulting Group will post 8.71 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on HURN. Barrington Research reaffirmed an “outperform” rating on shares of Huron Consulting Group in a research note on Wednesday, June 17th. Truist Financial reduced their target price on shares of Huron Consulting Group to $155.00 and set a “buy” rating on the stock in a research note on Tuesday, June 9th. Weiss Ratings downgraded shares of Huron Consulting Group from a “hold (c+)” rating to a “hold (c)” rating in a research note on Tuesday, May 12th. Wall Street Zen lowered shares of Huron Consulting Group from a “buy” rating to a “hold” rating in a report on Sunday, July 12th. Finally, Wedbush reaffirmed an “outperform” rating and issued a $160.00 price objective on shares of Huron Consulting Group in a research note on Wednesday, May 6th. Four equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $184.25.

Insider Buying and Selling

In other Huron Consulting Group news, Director Debra Zumwalt sold 598 shares of Huron Consulting Group stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $118.44, for a total value of $70,827.12. Following the sale, the director owned 27,201 shares of the company’s stock, valued at $3,221,686.44. This trade represents a 2.15% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Joy Brown sold 1,821 shares of the business’s stock in a transaction dated Friday, May 22nd. The shares were sold at an average price of $105.01, for a total value of $191,223.21. Following the completion of the sale, the director owned 8,575 shares in the company, valued at approximately $900,460.75. This trade represents a 17.52% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 2,862 shares of company stock valued at $314,519. 2.07% of the stock is owned by company insiders.

Institutional Investors Weigh In On Huron Consulting Group

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Mcguire Capital Advisors Inc. acquired a new stake in shares of Huron Consulting Group in the fourth quarter valued at approximately $50,000. Invesco Ltd. raised its holdings in Huron Consulting Group by 12.2% during the fourth quarter. Invesco Ltd. now owns 247,393 shares of the business services provider’s stock worth $42,777,000 after acquiring an additional 26,933 shares in the last quarter. Susquehanna Fundamental Investments LLC boosted its position in Huron Consulting Group by 243.8% during the fourth quarter. Susquehanna Fundamental Investments LLC now owns 15,001 shares of the business services provider’s stock valued at $2,594,000 after purchasing an additional 10,638 shares during the last quarter. Osterweis Capital Management Inc. bought a new position in Huron Consulting Group in the fourth quarter valued at approximately $8,414,000. Finally, Janus Henderson Group PLC grew its stake in Huron Consulting Group by 688.5% in the fourth quarter. Janus Henderson Group PLC now owns 65,682 shares of the business services provider’s stock valued at $11,356,000 after purchasing an additional 57,352 shares in the last quarter. Institutional investors and hedge funds own 93.90% of the company’s stock.

Huron Consulting Group Company Profile

Huron Consulting Group (NASDAQ:HURN) is a global professional services firm that advises organizations across a range of industries on strategy, operations and technology. Founded in 2002 and headquartered in Chicago, the company helps clients address complex business challenges such as performance improvement, digital transformation and organizational change. Huron’s consultants work alongside executive leadership teams to develop and implement tailored solutions that drive growth, increase efficiency and manage risk.

Huron’s service offerings encompass business and financial advisory, healthcare performance improvement, life sciences consulting, higher education and research lifecycle support, as well as legal and regulatory consulting.